Vietnam's Ministry of Industry and Trade considers new tobacco law

Oct.24.2024
Vietnam's Ministry of Industry and Trade considers new tobacco law
Vietnam's Ministry of Industry and Trade is developing new regulations for tobacco management, including e-cigarettes and heated tobacco products.

The Ministry of Industry and Trade in Vietnam is currently studying and drafting a new decree on tobacco management to replace the current Decree No. 67/2013/ND-CP, according to a recent report by Baodautu.

 

In this report, the Ministry of Industry and Trade plans to propose specific regulations for the management of e-cigarettes and heated tobacco products (HTP). The Ministry of Commerce will work with the Ministry of Health and other relevant departments to finalise the draft and report to the government.

 

Vietnam's Minister of Industry and Trade, Nguyen Hong Dien, reported to the National Assembly on the implementation of resolutions related to inquiries and commitments made at the previous session on industry and trade issues. During the seventh session of the National Assembly, many members expressed concerns about the potential harm of new tobacco products, including e-cigarettes and HTP products, during discussions and questions to the Minister.

 

In early May 2024, a hearing on the government's responsibility to prevent and control the harm of e-cigarettes and HTP products, hosted by the National Assembly's Committee on Social Affairs in cooperation with the Committee on Cultural Education, attracted widespread public attention. According to reports from over 700 medical institutions, including hospitals directly under the Ministry of Health, provincial health bureaus and county health centres, there were 1,224 cases of hospital admissions due to the use of e-cigarettes and HTP products in 2023 alone.

 

The conclusion of the hearing pointed out that there are legal loopholes in the prevention and control of harm from e-cigarettes and HTP products. One of the main reasons is that various ministries and local governments have not yet unified their positions on the management of new tobacco products, resulting in slow implementation of government directives and delays in promulgating relevant legal documents.

 

During the seventh session of the National Assembly, some deputies continued to question the Minister of Industry and Commerce on how to address the issue of new tobacco products. The Minister told the National Assembly: "If the Ministry of Health confirms that the health hazards of new tobacco products reach a level that warrants a ban, the Ministry of Industry and Trade will support the prompt amendment of relevant laws to ensure that these products cannot be marketed in Vietnam.
 

At present, the results of the implementation of this pledge are still "under review" and it is not yet clear when the contents related to the management of e-cigarettes and HTP products will be finalised. The report also notes that the Ministry of Health has been tasked with reviewing laws and regulations on the prevention and control of harm from e-cigarettes and HTP products, and has made recommendations to amend the Tobacco Hazards Prevention and Control Law. At the same time, the Ministry of Health is responsible for developing solutions to regulate new tobacco products based on its authority or by submitting proposals to relevant agencies.
 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI reshuffles U.S. footprint: Swedish Match to shut Richmond office in April; most staff may be relocated
PMI reshuffles U.S. footprint: Swedish Match to shut Richmond office in April; most staff may be relocated
Swedish Match, a unit of Philip Morris International (PMI), will close its office in Richmond, Virginia, in April 2026 and eliminate 135 positions. PMI said the move is tied to adjustments in its U.S. operating footprint.
Feb.03
Japan Tobacco seeks retail price hike for Ploom tobacco sticks; EVO and others to rise by 30 yen per pack
Japan Tobacco seeks retail price hike for Ploom tobacco sticks; EVO and others to rise by 30 yen per pack
Japan Tobacco (JT) said it has applied to raise retail prices for its heated tobacco-related products from April 1, 2026, covering 37 variants of Ploom tobacco sticks and with capsules, with most increases at 20–30 yen per pack (about $0.13–$0.19).
Jan.28 by 2FIRSTS.ai
U.S. Court Rules Zyn Marketing Dispute Can Proceed, Rejects Philip Morris International’s Bid to Dismiss
U.S. Court Rules Zyn Marketing Dispute Can Proceed, Rejects Philip Morris International’s Bid to Dismiss
A U.S. federal court in Florida denied Philip Morris International and its subsidiaries’ motion to dismiss, allowing consumers to proceed with claims under the Florida Deceptive and Unfair Trade Practices Act alleging that Zyn nicotine pouches’ “tobacco-free” marketing is misleading. The court held that the allegations do not amount to a fraud claim and may move forward to the merits stage.
Dec.15 by 2FIRSTS.ai
The Spark of Reason| 2Firsts 2026 New Year Message
The Spark of Reason| 2Firsts 2026 New Year Message
Looking ahead to 2026, we do so with genuine anticipation. This will be a milestone year—the dawn of a new era.
Jan.01
Product | VOZOL launches new GEAR-series device in the UK and UAE, featuring a 2.1-inch colour screen and sound interaction
Product | VOZOL launches new GEAR-series device in the UK and UAE, featuring a 2.1-inch colour screen and sound interaction
Vape brand VOZOL has recently listed a disposable shisha-style product, the GEAR HOOKAH 40000, on its official website. Public information shows the device comes with a 26ml e-liquid capacity, offers 3mg/ml and 5mg/ml nicotine strengths, and is marketed at 25,000–40,000 puffs. It is currently available via selected online retail channels in the UK and the UAE.
Feb.04 by 2FIRSTS.ai
Philippine FDA Requires Licenses for Vape Products with Medical Claims
Philippine FDA Requires Licenses for Vape Products with Medical Claims
The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.
Dec.22 by 2FIRSTS.ai